Markus Glatt

2.3k total citations
34 papers, 1.9k citations indexed

About

Markus Glatt is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Markus Glatt has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in Markus Glatt's work include Bone health and treatments (8 papers), Inflammatory mediators and NSAID effects (8 papers) and Bone Metabolism and Diseases (6 papers). Markus Glatt is often cited by papers focused on Bone health and treatments (8 papers), Inflammatory mediators and NSAID effects (8 papers) and Bone Metabolism and Diseases (6 papers). Markus Glatt collaborates with scholars based in Switzerland, United Kingdom and Australia. Markus Glatt's co-authors include Kay Brune, Peter Gräf, Bernhard A. Peskar, Natalie A. Sims, Matthew T. Gillespie, Jonathan R. Green, A. Pataki, László Urbán, Bruce Kidd and Stephen J. Medhurst and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Markus Glatt

34 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Glatt Switzerland 19 584 553 401 347 267 34 1.9k
Naokazu Nagata Japan 26 825 1.4× 1.3k 2.4× 181 0.5× 291 0.8× 257 1.0× 95 2.4k
Edward F. Voelkel United States 26 916 1.6× 993 1.8× 681 1.7× 190 0.5× 257 1.0× 38 2.6k
Jean H.M. Feyen United States 34 1.1k 1.9× 1.9k 3.5× 171 0.4× 143 0.4× 351 1.3× 77 3.3k
G. Allen Nickols United States 28 553 0.9× 1.1k 2.0× 96 0.2× 918 2.6× 180 0.7× 47 2.7k
Glenda L. Wong United States 19 592 1.0× 1.1k 1.9× 103 0.3× 199 0.6× 195 0.7× 29 2.1k
Stuart H. Ralston United Kingdom 29 915 1.6× 1.7k 3.1× 192 0.5× 351 1.0× 1.2k 4.6× 49 3.2k
V. P. Michelangeli Australia 26 832 1.4× 1.5k 2.8× 117 0.3× 186 0.5× 169 0.6× 52 3.2k
Lewis R. Chase United States 18 385 0.7× 1.3k 2.3× 114 0.3× 331 1.0× 72 0.3× 23 2.6k
Hong Qi United States 17 256 0.4× 567 1.0× 115 0.3× 166 0.5× 196 0.7× 27 1.5k
E. Arrigoni Italy 28 324 0.6× 665 1.2× 68 0.2× 217 0.6× 44 0.2× 91 1.9k

Countries citing papers authored by Markus Glatt

Since Specialization
Citations

This map shows the geographic impact of Markus Glatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Glatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Glatt more than expected).

Fields of papers citing papers by Markus Glatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Glatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Glatt. The network helps show where Markus Glatt may publish in the future.

Co-authorship network of co-authors of Markus Glatt

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Glatt. A scholar is included among the top collaborators of Markus Glatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Glatt. Markus Glatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glatt, Markus, Roy Brouwer, & Ivana Logar. (2019). Combining Risk Attitudes in a Lottery Game and Flood Risk Protection Decisions in a Discrete Choice Experiment. Environmental and Resource Economics. 74(4). 1533–1562. 8 indexed citations
2.
Eckhardt, C., Sylwester Gogolewski, Markus Glatt, et al.. (2006). Mechanical and radiological assessment of the influence of rhTGFβ‐3 on bone regeneration in a segmental defect in the ovine tibia: Pilot study. Journal of Orthopaedic Research®. 24(8). 1670–1678. 23 indexed citations
3.
Sims, Natalie A., Brendan J. Jenkins, J Quinn, et al.. (2004). Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. Journal of Clinical Investigation. 113(3). 379–389. 151 indexed citations
4.
Glatt, Markus, et al.. (2004). Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid. Osteoporosis International. 15(9). 707–15. 51 indexed citations
5.
Sims, Natalie A., Jonathan R. Green, Markus Glatt, et al.. (2004). Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis. Arthritis & Rheumatism. 50(7). 2338–2346. 107 indexed citations
6.
Widler, Leo, Knut A. Jaeggi, Markus Glatt, et al.. (2002). Highly Potent Geminal Bisphosphonates. From Pamidronate Disodium (Aredia) to Zoledronic Acid (Zometa). Journal of Medicinal Chemistry. 45(17). 3721–3738. 266 indexed citations
7.
Walker, Katharine, Stephen J. Medhurst, Bruce Kidd, et al.. (2002). Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain. 100(3). 219–229. 70 indexed citations
8.
Medhurst, Stephen J., Katherine Walker, Bruce Kidd, et al.. (2002). A rat model of bone cancer pain. Pain. 96(1). 129–140. 262 indexed citations
9.
Glatt, Markus, et al.. (2001). The bisphosphonate zoledronate prevents vertebral bone loss in mature estrogen-deficient rats as assessed by micro-computed tomography. European Cells and Materials. 1. 18–26. 19 indexed citations
10.
Šuša, Mira, Markus Glatt, & Anna Teti. (2001). Tumor Bone Diseases: Molecular Mechanisms and Opportunities for Novel Treatments. PubMed. 1(3). 313–329. 4 indexed citations
11.
Pataki, A., et al.. (1996). Anabolic effects of β2-agonists, formoterol and salbutamol on cancellous bone of ovariectomized (OVX) rat. Bone. 19(3). 158–158. 15 indexed citations
12.
Geiger, Thomas, et al.. (1994). CGP 47969A: effect on collagen induced arthritis in DBA/1 mice.. PubMed. 21(11). 1992–7. 15 indexed citations
13.
Glatt, Markus, et al.. (1986). Delayed type hypersensitivity (DTH) to type II collagen (CII) in DBA-1 mice.. PubMed. 65(2). 329–35. 7 indexed citations
14.
Glatt, Markus, Paul Dieppe, & D. A. Willoughby. (1979). Crystal-induced inflammation, enzyme release and the effects of drugs in the rat pleural space.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(3). 251–8. 19 indexed citations
15.
Peskar, Bernhard A., Markus Glatt, Henning Anhut, & Kay Brune. (1978). Effect of imidazole on prostaglandin and thromboxane accumulation in urate arthritis. European Journal of Pharmacology. 50(4). 437–441. 5 indexed citations
16.
Deporter, Douglas, Paul Dieppe, Markus Glatt, & D. A. Willoughby. (1977). The relation of cyclic AMP levels to phagocytosis and enzyme release in acute inflammation in vivo. The Journal of Pathology. 121(3). 129–139. 13 indexed citations
17.
Glatt, Markus, et al.. (1977). Prostaglandin release from macrophages: An assay system for anti-inflammatory drugs in vitro. Inflammation Research. 7(3). 321–326. 60 indexed citations
18.
Brune, Kay, Markus Glatt, & Peter Gräf. (1976). Mechanisms of action of anti-inflammatory drugs. General Pharmacology The Vascular System. 7(1). 27–IN1. 103 indexed citations
19.
Glatt, Markus, Bernhard A. Peskar, & Kay Brune. (1974). Leukocytes and prostaglandins in acute inflammation. Cellular and Molecular Life Sciences. 30(11). 1257–1259. 36 indexed citations
20.
Brune, Kay, et al.. (1973). Correlation between Antimicrobial Activity and Peroxidase Content of Leukocytes. Nature. 245(5422). 209–210. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026